Publications de Catherine NOGUES
Primary tabs
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
American Journal of Human Genetics
2021
;
108
(10)
:
1907-1923.
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study.
JNCI Cancer Spectrum
2021
;
2
(2)
:
pky023.
A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers.
BMC Medical Research Methodology
2021
;
21
(1)
:
155.
Gene‐ and pathway‐level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
International Journal of Cancer
2021
;
148
(8)
:
1895-1909.
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
American Journal of Obstetrics and Gynecology
2021
;
225
(1)
:
51.e1-51.e17.
National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract.
European Journal of Medical Genetics
2020
;
63
(12)
:
104080.
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Genetics in Medicine
2020
;
22
(10)
:
1653-1666.
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Breast Cancer Research
2020
;
22
(1)
:
8.
Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: results from The BRCA1 and BRCA2 Cohort Consortium.
Cancer Epidemiology, Biomarkers and Prevention
2019
;
27
:
cebp.0546.2019.
Les femmes à haut risque de cancer du sein : quelle attitude ?
La Presse Médicale
2019
;
48
(10)
:
1092-1100.
Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France.
Psycho-Oncology
2019
;
28
(9)
:
1894-1900.
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
International Journal of Cancer
2019
;
144
(8)
:
1962-1974.
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations.
JNCI Cancer Spectrum
2018
;
2
(4)
:
pky078.
The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition.
Bulletin du Cancer
2018
;
105
(10)
:
907-917.
How Can Contingent Valuation Inform the Bioethics Debate? Evidence from a Survey on Hereditary Cancers in France.
Revue Economique
2017
;
68
(3)
:
379--404.
Mutation screening of MIR146A/B and BRCA1/2 3′-UTRs in the GENESIS study.
European Journal of Human Genetics
2016
;
24
(9)
:
1324-1329.
“Maybe they have found something new” participants’ views on returning cohort psychosocial survey results.
Health Expectations
2015
;
18
(6)
:
2425-2436.
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2.
PLoS ONE
2015
;
10
(9)
:
e0136192.
Impact of BRCA1/2 mutation on young women’s 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort).
Familial Cancer
2015
;
14
(2)
:
273-279.
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers.
Cancer Epidemiology, Biomarkers and Prevention
2015
;
24
(4)
:
698-707.
[Having a child and PND/PGD access in women with a BRCA1/2 mutation? Different approach whether ill or healthy].
Bulletin du Cancer
2014
;
101
(11)
:
1001-1008.
Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
Psycho-Oncology
2014
;
23
(4)
:
420-427.
Psychometric properties of a French version of a Dutch scale for assessing breast and body image (BBIS) in healthy women.
BMC Women's Health
2013
;
13
(1)
:
24.
Cancer risk management strategies and perceptions of unaffected women five years after predictive genetic testing for BRCA1/2 mutations.
European Journal of Human Genetics
2011
.
Variation in breast cancer risk with mutation position smoking alcohol and chest X-ray history in the French National BRCA1/2 carrier cohort (GENEPSO).
Breast Cancer Research and Treatment
2011
;
130
(3)
:
927-938.
Variation of Breast Cancer Risk in the French National BRCA1/2 Carrier Cohort (GENEPSO).
2009
;
33
(8)
:
page 819, 229.
[Cancer genetics: estimation of the needs of the population in France for the next ten years].
Bulletin du Cancer
2009
;
96
(9)
:
875-900.
BRCA penetrance for breast and ovarian cancers: a heterogeneity study.
2006
;
31
(5)
:
page 474, 86.
Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.
Journal of Clinical Oncology
2006
;
24
(21)
:
3361-6.
Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).
J Natl Cancer Inst
2006
;
98
(8)
:
535-44.
Estimation du risque de cancer associé aux gènes BRCA : étude GENECAN.
2006
;
22
(HS2)
:
page 19, CO43/203.